| Dr Jennifer Levy Woelk, MD | |
|
2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 | |
| (970) 488-1666 | |
| (970) 472-9381 |
| Full Name | Dr Jennifer Levy Woelk |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 23 Years |
| Location | 2637 Midpoint Dr Ste B, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043280043 | NPI | - | NPPES |
| P00425164 | Other | CO | RAILROAD MEDICARE |
| 90236831 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 43661 (Colorado) | Primary |
| 207R00000X | Internal Medicine | 43661 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Colorado Hospitalists Professional Llc | 8325147507 | 68 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "Voters in Arizona, Colorado and Oklahoma will have the chance Tuesday to repudiate the new health care law's keystone provision, one that requires almost everyone to have health insurance or face a tax penalty beginning in 2014" (Miles, 10/30).
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.
A 25 per cent increase in high blood pressure screening in 19 developing countries would reduce the number of cardiovascular disease (CVD) events and deaths that occur each year by up to 3 per cent in these countries.
Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment exists, the National Institute of Allergy and Infectious Diseases (NIAID) has announced.
› Verified 2 days ago
| Entity Name | Pathways Hospice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063444305 PECOS PAC ID: 7911914577 Enrollment ID: O20060307000795 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "Voters in Arizona, Colorado and Oklahoma will have the chance Tuesday to repudiate the new health care law's keystone provision, one that requires almost everyone to have health insurance or face a tax penalty beginning in 2014" (Miles, 10/30).
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.
A 25 per cent increase in high blood pressure screening in 19 developing countries would reduce the number of cardiovascular disease (CVD) events and deaths that occur each year by up to 3 per cent in these countries.
Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment exists, the National Institute of Allergy and Infectious Diseases (NIAID) has announced.
› Verified 2 days ago
| Entity Name | Northern Colorado Hospitalists Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831315662 PECOS PAC ID: 8325147507 Enrollment ID: O20070628000638 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "Voters in Arizona, Colorado and Oklahoma will have the chance Tuesday to repudiate the new health care law's keystone provision, one that requires almost everyone to have health insurance or face a tax penalty beginning in 2014" (Miles, 10/30).
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.
A 25 per cent increase in high blood pressure screening in 19 developing countries would reduce the number of cardiovascular disease (CVD) events and deaths that occur each year by up to 3 per cent in these countries.
Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment exists, the National Institute of Allergy and Infectious Diseases (NIAID) has announced.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Levy Woelk, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (970) 488-1666 | Dr Jennifer Levy Woelk, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (970) 488-1666 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "Voters in Arizona, Colorado and Oklahoma will have the chance Tuesday to repudiate the new health care law's keystone provision, one that requires almost everyone to have health insurance or face a tax penalty beginning in 2014" (Miles, 10/30).
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.
A 25 per cent increase in high blood pressure screening in 19 developing countries would reduce the number of cardiovascular disease (CVD) events and deaths that occur each year by up to 3 per cent in these countries.
Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment exists, the National Institute of Allergy and Infectious Diseases (NIAID) has announced.
› Verified 2 days ago
Victoria Anne Clipsham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Dr. Nancy Terrell Maller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Mrs. Kelly Elizabeth Mistry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 434-243-4394 Fax: 434-243-4873 | |
Dr. Rebecca Rain Jackson, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1032 Luke St Ste 1, Fort Collins, CO 80524 Phone: 970-568-5810 | |
Eduardo Cruz Pareja, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr, Fort Collins, CO 80525 Phone: 970-488-1666 | |
Dr. Nathan Michael Smith, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 |